Salt Lake City, UT, United States of America

Bryan E Welm

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.5

ph-index = 1


Location History:

  • Edmond, OK (US) (2019)
  • Salt Lake City, UT (US) (2022)

Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Bryan E Welm: Innovator in Therapeutic Compositions

Introduction

Bryan E Welm is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of therapeutic compositions, particularly in the development of compounds with selective activity against cancer cells. With a total of 2 patents, his work is paving the way for innovative treatments in oncology.

Latest Patents

Bryan E Welm's latest patents include "Compositions and methods comprising substituted 2-aminoimidazoles" and "Compositions and methods comprising 2-(acylamino)imidazoles." Both inventions focus on 2-(acylamino)imidazoles that exhibit therapeutic activity, specifically targeting cancer cells. These patents detail methods of using and preparing these compounds, showcasing their potential in cancer treatment.

Career Highlights

Throughout his career, Bryan has worked with various organizations, including Curza Global, LLC and the University of Utah Research Foundation. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research in therapeutic innovations.

Collaborations

Some of Bryan's notable coworkers include Ryan E Looper and Justin M Salvant. Their collaborative efforts have contributed to the advancement of research in therapeutic compositions.

Conclusion

Bryan E Welm's innovative work in the field of therapeutic compositions highlights his commitment to developing effective cancer treatments. His patents and collaborations reflect a dedication to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…